Literature DB >> 17097911

The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?

J B Andersen1, B A Hassel.   

Abstract

The interferon-stimulated gene, 15 kDa (ISG15) is an interferon regulated gene that is induced as a primary response to diverse microbial and cell stress stimuli, and encodes the founding member of the ubiquitin-like protein family. ISG15 post-translationally modifies proteins via a pathway parallel to, and partially overlapping with, that of ubiquitin. In addition, ISG15 is released from cells to mediate extracellular cytokine-like activities. Although the biological activities of ISG15 have yet to be fully elucidated, it is clear that ISG15 has the capacity to modulate diverse cellular and physiologic functions. Consistent with this view, alterations in the ISG15 pathway have been identified in human tumors and in tumor cell lines. Here we review evidence of a role for ISG15 as an endogenous tumor suppressor that, when dysregulated in malignant cells, can be subverted to promote oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097911     DOI: 10.1016/j.cytogfr.2006.10.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  36 in total

Review 1.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

2.  Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases.

Authors:  Berati Cerikan; Elmar Schiebel
Journal:  Small GTPases       Date:  2017-03-13

3.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

4.  ISG15 as a novel tumor biomarker for drug sensitivity.

Authors:  Shyamal D Desai; Laurence M Wood; Yu-Chen Tsai; Tao-Shih Hsieh; Jeffrey R Marks; Georgia L Scott; Beppino C Giovanella; Leroy F Liu
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

5.  Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers.

Authors:  Jun Tao; Ping Hua; Jing Wen; Yi Hu; Hong Yang; Xuan Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Telomere length regulates ISG15 expression in human cells.

Authors:  Zhenjun Lou; Jun Wei; Harold Riethman; Joseph A Baur; Regina Voglauer; Jerry W Shay; Woodring E Wright
Journal:  Aging (Albany NY)       Date:  2009-07-17       Impact factor: 5.682

7.  Telomere length influences cancer cell differentiation in vivo.

Authors:  Kyotaro Hirashima; Toshiro Migita; Shigeo Sato; Yukiko Muramatsu; Yuichi Ishikawa; Hiroyuki Seimiya
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

8.  Roles of miR-138 and ISG15 in oral squamous cell carcinoma.

Authors:  Qimei Zhang; Yi He; Minhai Nie; Wei Cai
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

Review 9.  Do molecular signals from the conceptus influence endometrium decidualization in rodents?

Authors:  Jennifer L Herington; Brent M Bany
Journal:  J Exp Zool B Mol Dev Evol       Date:  2009-12-15       Impact factor: 2.656

Review 10.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.